DNLI vs IPG
Denali Therapeutics Inc (DNLI) versus IPG (IPG) — a side-by-side from cached financials, not a winner call.
Denali Therapeutics Inc (DNLI) is a biotechnology company listed on US.
IPG (IPG) common stock.
Latest reported DNLI revenue for 2026-06-30 was $3.6M. Net income was -$256.0M. DNLI currently screens at market cap $2.11B.
IPG does not have a complete income-statement cache yet.
DNLI currently screens at market cap $2.11B.
Not investment advice. Open the DNLI and IPG stock pages for the full models.
Not investment advice.